Figure 4.
Rapamycin and CCI-779 induce G0/G1 arrest of BM-ECs. Cell-cycle analyses were performed at 24 hours, using flow cytometry bivariate distributions of BrdU incorporation versus DNA content (PI). BM-ECs were stimulated with cytokine media/EGM2 or 10% vol/vol leukemia plasma and treated with rapamycin (10, 100 ng/mL) (A) or with CCI-779 (10 nM) (B). Data represent mean ± SEM of experiments using BM-ECs from 3 different donors and 10 different ALL patients. *Significance level of P < .05 using a 2-tailed paired t test. (C) BM-ECs were cytokine/serum deprived for 12 hours (EBM) and then stimulated with cytokine media/EGM2 with or without rapamycin (10 ng/mL) for 12 or 24 hours. Protein levels of cyclin D1, p27kip1, and p21cip1 and the phosphorylation status of cdk2 were determined by Western blot. Arrow indicates correct band. Results are representative of 3 (12-hour time point) or 5 (24-hour time point) different BM-ECs tested.